Clinical Trial Update: Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B [Phase 4]

View source ↗

Summary

This document reports a Phase 4 clinical trial evaluating combination or sequential therapy of peginterferon alfa-2a and entecavir for chronic hepatitis B; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Peginterferon alfa-2a (peginterferon alfa-2a)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Chronic Hepatitis B | Phase 4 | Status: UNKNOWN